Pharma, health and science writer at Reuters. Any opinions are mine.

Experts sound alarm as diabetes fuels cases of TB

reuters.com — Tuberculosis (TB), which killed an estimated 1.5 million people last year according to the World Health Organization (WHO), is caused by bacteria that lie dormant in many people. However, diabetics TB become sick from latent TB infection far more often than other people because their immune systems are compromised -- a fact that could unleash an epidemic of co-infection as diabetes rates soar along with growing obesity.

Get your facts right: Italy, U.S. come bottom in modern life survey

reuters.com — Swedes and Germans do best, although even they consistently get things wrong, according to a survey of 14 industrialized countries released on Wednesday. The analysis by market research organization Ipsos MORI shows how far perceptions stray from reality across a range of issues as people struggle to get a precise handle on aspects of society that are seen as risks or worries.

In race for Ebola vaccines, technical hurdles loom large

reuters.com — Credit: Reuters/Mathilde Missioneiro/WHO/Handout via Reuters A medical staff holds a package of an experimental candidate vaccine rVSV-ZEBOV against Ebola virus disease at the University hospital in Geneva October 22, 2014. The challenges include finding sufficient sterile capacity for filling and packaging finished vials, getting fast quality approvals from regulators, and building a supply chain in Africa for products that must be stored at minus 80 degrees Celsius.

Immune-system drugs raise cost concerns

dispatch.com — MADRID - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects, but their high cost is a growing concern. Drugs that help immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a year higher.

AstraZeneca cancer drug pipeline gets boost from European green light

reuters.com — Credit: Reuters/Phil Noble A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. The green light from the European Medicines Agency (EMA) for olaparib, or Lynparza, is welcome news since the product hit a road bump in June when a U.S. panel voted against its accelerated approval.

ANALYSIS-Fixing "Ebolanomics" in pursuit of vaccines and drugs

af.reuters.com — Unprecedented Ebola outbreak demands new business model * Experts see long-term potential for government stockpiles * Drug pricing needs to account for very poor countries By Kate Kelland and Ben Hirschler LONDON,

Drugmakers may need indemnity for fast-tracked Ebola vaccines

ottawasun.com — Drugmakers are looking for some kind of indemnity from governments or multilateral agencies against possible losses or claims arising from the widespread emergency use of new Ebola vaccines in Africa.

Fixing 'Ebolanomics' in pursuit of vaccines and drugs

reuters.com — Credit: Reuters/Public Health Agency of Canada/Handout Scientists at the National Microbiology Lab in Winnipeg, Manitoba, prepare an experimental Ebola vaccine for shipment to the World Health Organization (WHO) in Geneva in this undated handout picture released October 18, 2014.

Drugmakers may need indemnity for fast-tracked Ebola vaccines

finance.yahoo.com — Governments or multilateral agencies may offer indemnity * Topic expected to be discussed at Geneva vaccines meeting LONDON/GENEVA, Oct 23 (Reuters) - Drugmakers are looking for some kind of indemnity from governments or multilateral agencies for the widespread emergency use of new Ebola vaccines in Africa.

Drugmakers may need indemnity for fast-tracked Ebola vaccines

reuters.com — Topic expected to be discussed at Geneva vaccines meeting * Companies say issue won't delay accelerated vaccine work By Ben Hirschler and Stephanie Nebehay LONDON/GENEVA, Oct 23 (Reuters) - Drugmakers are looking for some kind of indemnity from governments or multilateral agencies for the widespread emergency use of new Ebola vaccines in Africa.
More Articles →
Oct 31, 2014

RT @stevesilberman: Still the best Jack O'Lantern I've ever seen. By artists Mark Kobasz and Chris Houston. pic.twitter.com/hVyINRRKAf

Oct 30, 2014

#Bristol-Myers shares jump 3.5% as immunotherapy #nivolumab shows good results in lung cancer trial reut.rs/13jUGgR $BMY

Oct 28, 2014

Another bad day for #Sanofi CEO #Viehbacher as firm warns key diabetes business will slow in 2015 and shares fall 7% reut.rs/1wxxVQj



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Ben Hirschler, email reutersbenhir@muckrack.com.


Share This Profile